TNF-α-IN-9

CAS No. 2054199-25-4

TNF-α-IN-9( —— )

Catalog No. M36913 CAS No. 2054199-25-4

TNF-α-IN-9 is an NDM-1 inhibitor-3 analog and is a TNF-α inhibitor.TNF-α-IN-9 shows low inhibitory activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 103 In Stock
5MG 145 In Stock
10MG 214 In Stock
25MG 351 In Stock
50MG 532 In Stock
100MG 745 In Stock
500MG 1512 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    TNF-α-IN-9
  • Note
    Research use only, not for human use.
  • Brief Description
    TNF-α-IN-9 is an NDM-1 inhibitor-3 analog and is a TNF-α inhibitor.TNF-α-IN-9 shows low inhibitory activity.
  • Description
    TNF-α-IN-9 (compound 48) is a analog of NDM-1 inhibitor-3 (HY-150758). TNF-α-IN-9 is a TNF-α inhibitor. TNF-α-IN-9 shows low inhibitory activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    TNF
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2054199-25-4
  • Formula Weight
    282.29
  • Molecular Formula
    C17H14O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C\1C=2C(C/C1=C\C3=CC(O)=C(OC)C=C3)=CC=CC2O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kadayat TM, et al. Discovery and structure-activity relationship studies of 2-benzylidene-2,3-dihydro-1H-inden-1-one and benzofuran-3(2H)-one derivatives as a novel class of potential therapeutics for inflammatory bowel disease. Eur J Med Chem. 2017 Sep 8;137:575-597.?
molnova catalog
related products
  • Lenalidomide hemihyd...

    Lenalidomide hemihydrate is a TNF-α secretion inhibitor (IC50 = 13 nM).

  • Varlilumab

    Varlilumab (CDX-1127) is a novel human IgG1 anti-CD27 monoclonal antibody with antitumor activity, useful for studying advanced solid tumors.

  • Certolizumab pegol

    Certolizumab pegol (Certolizumab) is a polyethylene glycolated and humanized anti-TNF-α monoclonal antibody for the study of autoimmune diseases such as rheumatoid arthritis (RA), psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA).